These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16094309)

  • 1. Variable expressivity of the clinical and biochemical phenotype associated with the apolipoprotein E p.Leu149del mutation.
    Faivre L; Saugier-Veber P; Pais de Barros JP; Verges B; Couret B; Lorcerie B; Thauvin C; Charbonnier F; Huet F; Gambert P; Frebourg T; Duvillard L
    Eur J Hum Genet; 2005 Nov; 13(11):1186-91. PubMed ID: 16094309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].
    Nguyen TT; Kruckeberg KE; O'Brien JF; Ji ZS; Karnes PS; Crotty TB; Hay ID; Mahley RW; O'Brien T
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4354-8. PubMed ID: 11095479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited lipemic splenomegaly and the spectrum of apolipoprotein E p.Leu167del mutation phenotypic variation.
    Okorodudu DE; Crowley MJ; Sebastian S; Rowell JV; Guyton JR
    J Clin Lipidol; 2013; 7(6):566-72. PubMed ID: 24314356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
    Hidaka H; Tozuka M; Hidaka E; Yamauchi K; Ota H; Honda T; Katsuyama T
    Ann Clin Lab Sci; 2001 Apr; 31(2):163-70. PubMed ID: 11337906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate intake, serum lipids and apolipoprotein E phenotype show association in children.
    Ruottinen S; Rönnemaa T; Niinikoski H; Lagström H; Saarinen M; Pahkala K; Kaitosaari T; Viikari J; Simell O
    Acta Paediatr; 2009 Oct; 98(10):1667-73. PubMed ID: 19563454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
    Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
    Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial chylomicronemia caused by a novel type of mutation in the APOE-CI-CIV-CII gene cluster encompassing both the APOCII gene and the first APOCIV gene mutation: APOCII-CIV(Nijmegen).
    de Graaf J; Hoffer MJ; Stuyt PM; Frants RR; Stalenhoef AF
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1084-7. PubMed ID: 10891375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia.
    Zhao SP; Van den Maagdenberg AM; Vroom TF; Van 't Hooft FM; Gevers Leuvens JA; Havekes LM; Frants RR; Van der Laarse A; Smelt AH
    Clin Sci (Lond); 1994 Mar; 86(3):323-9. PubMed ID: 8156744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes.
    Fiegenbaum M; de Andrade FM; Hutz MH
    Clin Chim Acta; 2007 May; 380(1-2):175-81. PubMed ID: 17367769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sea-blue histiocyte syndrome. Review of the literature apropos of a case of idiopathic splenomegaly in the adult].
    Vacher-Lavenu MC; Baron-Selme V; Abelanet R; Boissonnas A; Laroche C
    Sem Hop; 1984 May; 60(19):1333-41. PubMed ID: 6326324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
    Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
    Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
    Rontu R; Ojala P; Hervonen A; Goebeler S; Karhunen PJ; Nikkilä M; Kunnas T; Jylhä M; Eklund C; Hurme M; Lehtimäki T
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):265-70. PubMed ID: 16487435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Li LS
    J Nephrol; 2008; 21(1):110-7. PubMed ID: 18264944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: allele frequency and relation to serum lipid concentrations.
    Duman BS; Oztürk M; Yilmazer S; Hatemi H
    Diabetes Nutr Metab; 2004 Oct; 17(5):267-74. PubMed ID: 16295048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo metabolism of VLDL-apolipoprotein-B, -CIII and -E in normolipidemic subjects.
    Dinkel RE; Barrett PH; Demant T; Parhofer KG
    Nutr Metab Cardiovasc Dis; 2006 Apr; 16(3):215-21. PubMed ID: 16580589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
    Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
    Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.